<DOC>
	<DOC>NCT01927562</DOC>
	<brief_summary>The purpose of this study is to assess the safety and feasibility of the Fractyl Duodenal Remodeling System for the treatment of patients with poorly controlled Type 2 Diabetes.</brief_summary>
	<brief_title>Initial Clinical Evaluation of an Endoscopic Therapy for Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Participants Age &gt; 28 years and â‰¤ 75 years Male or Female Participants who have signed an informed consent form Participants diagnosed with Type I Diabetes or with a history of ketoacidosis Participants with an active systemic infection Participant with a known diagnosis or preexisting symptoms of systemic lupus erythematosus, scleroderma or other autoimmune connective tissue disorder</criteria>
	<gender>All</gender>
	<minimum_age>28 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>